Delhi’s Artificial Rain Plan To Fight Toxic Smog Fails— Here’s Why It Didn’t Work

Updated Oct 29, 2025 | 08:36 PM IST

SummaryDelhi’s experiment with artificial rain to combat rising air pollution fell short of expectations. In a joint effort with IIT Kanpur, the Delhi government carried out cloud seeding trials across several areas, hoping to trigger rainfall and reduce toxic smog. However, the rain plan failed. Keep reading for more details.
artificial cloud seeding delhi

Credits: PTI

Artificial Cloud Seeding Delhi: Delhi has long struggled with toxic air. The city often records high pollution levels throughout the year, and in an effort to provide cleaner air to residents, the Delhi government has been exploring cloud seeding or artificial rain for several months.

After more than five decades, Delhi finally carried out cloud seeding trials to trigger artificial rain and bring down rising pollution levels. The project was a joint effort between the Delhi government and the Indian Institute of Technology (IIT) Kanpur, conducted in areas such as Burari, Karol Bagh, Mayur Vihar, and Badli.

However, the experiment failed, as the India Meteorological Department (IMD) did not record any rainfall in the city.

Why Cloud Seeding Failed in Delhi?

According to an NDTV report, IIT Kanpur Director Manindra Agrawal said the attempt was “not completely successful” because the clouds did not have enough moisture. “For rain to form, moisture levels of at least 50 percent are ideal,” he said. “Today’s clouds only had about 15–20 percent moisture, which reduced the chances of rainfall.”

Despite the low humidity, Agrawal said the exercise gave researchers valuable experience and confidence that the method could work under more favorable conditions. While Delhi saw no rainfall, small traces were recorded in Noida (0.1 mm) and Greater Noida (0.2 mm). Two more flights will be carried out once suitable clouds appear.

A report released by the Delhi government on Tuesday evening showed a slight drop in pollution levels in areas where the seeding took place. According to PTI, PM2.5 levels fell marginally in Mayur Vihar, Karol Bagh, and Burari. Environment Minister Manjinder Singh Sirsa called it a “major scientific step” in tackling air pollution and said more trials, possibly up to 10, will be conducted until February if the results remain encouraging.

What Is Cloud Seeding?

Cloud seeding involves adding substances like silver iodide or dry ice to clouds to encourage rainfall or snowfall, reduce hail, or clear fog. It can be carried out using aircraft, rockets, or ground-based equipment.

The formula developed by IIT Kanpur includes silver iodide nanoparticles, iodised salt, and rock salt. These particles act as ice nuclei, helping moisture in the clouds condense and form rain. However, the process depends heavily on having the right level of humidity and moisture in the atmosphere.

Will a Third Round of Cloud Seeding Take Place?

A third round of trials is likely later this week, depending on IMD confirmation of suitable cloud conditions. Similar operations are expected in the coming days. Sirsa told ANI that IIT Kanpur has been collecting large-scale samples during the experiments and will submit a detailed report soon.

Globally, cloud seeding has produced mixed outcomes. China has reported success with using rockets, cannons, and drones to manage rainfall, including before the Olympics. In contrast, the United Arab Emirates faced criticism after last year’s floods in Dubai, raising questions about the method’s safety and reliability.

End of Article

A Mysterious New Fungal Infection Is Spreading In UK Hospitals, Health Expert Warns

Updated Oct 30, 2025 | 02:00 AM IST

SummaryHealth officials in the UK are warning hospitals about a newly emerging fungal infection that can live on the body and hospital surfaces for long periods. The yeast, classified by the World Health Organisation (WHO) as a critical priority pathogen, is spreading in healthcare settings and poses a serious threat to patients with weakened immune systems.
fungal infection london hospital

Credits: Canva

Health officials across the UK are on alert after identifying a new fungal infection spreading in hospitals. Known as Candidozyma auris (C. auris), this yeast has been named a critical priority pathogen by the World Health Organisation (WHO) because of its growing resistance to treatment and potential danger to vulnerable patients. The UK Health Security Agency (UKHSA) is now working with NHS England and other health partners to monitor rising detections of C. auris, which until recently had been rare in the country. Globally, the infection has been linked to a high death rate, raising concern for hospitalised patients with weakened immune systems.

What Is Candidozyma Auris?

C. auris is a type of fungus that can lead to severe infections, particularly among those who are already ill. Some strains have shown resistance to multiple antifungal drugs, making treatment difficult. It spreads most often in hospitals and long-term care facilities. According to the Cleveland Clinic, infections may include:

  • Ear infections
  • Wound infections
  • Urinary tract infections (UTIs)
  • Bloodstream infections that can spread throughout the body

Unlike other Candida species, C. auris does not typically live naturally on the body. People usually contract it from contaminated hospital surfaces or from someone who already has the infection. For healthy individuals, the risk of infection remains low.

How Common Are Candidozyma Auris Infections?

C. auris remains uncommon but is considered an emerging infectious disease due to the rising number of reported cases since 2019. Healthcare professionals are increasing infection-control measures to contain its spread in hospitals and care homes.

Symptoms Of Candidozyma Auris

The symptoms vary depending on which part of the body is infected. Common signs include:

  • Fever
  • Chills
  • Fatigue or extreme tiredness
  • Low blood pressure
  • Rapid heartbeat (tachycardia)
  • Low body temperature (hypothermia)
  • Ear pain, pressure, or a sense of fullness (in ear infections)
Because C. auris often affects people who are already seriously unwell, its symptoms may not always be obvious. Some individuals may carry the fungus without showing any signs but can still pass it on to others.

According to a UKHSA statement, C. auris was first discovered in 2009 in the ear of a patient in Japan and has since been detected in over 40 countries across six continents. The agency explains that the fungus is particularly concerning because it can survive for long periods on surfaces—even in hospital settings—and is often resistant to both standard medical treatments and disinfectants.

Since 2015, several long-lasting outbreaks of C. auris have occurred in UK hospitals, requiring intensive control measures to stop further transmission. Peaks in cases have mostly been linked to these outbreaks.

Can Candidozyma Auris Be Cured?

C. auris infections can often be treated with a type of antifungal medication called echinocandins. However, certain strains are developing resistance, making them more difficult to cure. In such cases, doctors may need to combine different drugs to eliminate the infection. Before starting any medication, it is important to consult a qualified healthcare professional for proper diagnosis and treatment advice.

End of Article

Dr. Amir Khadir Pleads Guilty Over Controversial Treatments for a Nonexistent Form of Lyme Disease

Updated Oct 29, 2025 | 10:50 AM IST

SummaryDr. Amir Khadir, a Quebec microbiologist and infectious disease specialist, pleaded guilty to 12 offences for providing long-term antibiotic treatments for “chronic” Lyme disease—a condition not recognized by science. Despite promising to limit prescriptions to 28 days, he treated patients for up to two years, defying medical guidelines and regulatory commitments.
Dr. Amir Khadir Pleads Guilty Over Controversial Treatments for a Nonexistent Form of Lyme Disease

Credits: Canva and Wikimedia Commons

Dr Amir Khadir, microbiologist and infectious disease specialist at Pierre-Le Gardeur Hospital in Terrebonne, Quebec, Canada pleaded guilty to 12 offences over his controversial treatment of Lyme disease. He had been treating patients with "chronic" Lyme disease since 2019 in his specialized clinic, affiliated to the hospital. However, science does not back that such a condition even exists, confirmed the disciplinary council of the Collège des médecins du Québec (CMQ).

In June 2020, he made a commitment to stop prescribing antibiotics beyond 28 days to treat people with Lyme disease, however, some patients have taken his medications for two years. His long-term antibiotic treatment lasted for more than four months up to two years in his patients.

Also Read: Is The White House Hiding Truth About President Donald Trump’s Health?

What Happened In The Past?

Dr Steven Lapointe, who is a CMQ trustee said that Dr Khadir "admitted four times rather than once that he had not respected his commitment. He spent much more time justifying himself than expressing regret, and even less remorse, for not having respected his commitment. [He made] his own law."

Dr Khadir justified his deed by saying that some of his desperate patients had recovered after prolonged course of antibiotics. He said that there were no complains from his patients about his approach. No complications were reported either.

Dr Khadir had earlier made the government aware of the need to undertake a research and was hoping to seek funding for the same. Le Journal de Montreal reports that he was not to offer antibiotic treatment for Lyme disease for more than 28 days, except as part of a hospital research project. However, as Montreal City News reports, that though he received the approval of the medical and political communities, the fundings had not come, as Quebec allocated the funds for a group of clinics specializing in long COVID and infectious diseases. Thus, he continued to offer antibiotic treatment beyond 28 days outside of a research setting.

"I regret not having done things in the right order. It was a lamentable error of judgment," he said.

Also Read: As U.S. Measles Cases Surge, Could The Country Lose Its Elimination Status?

What Is The Right Way To Treat Lyme Disease?

As per the Centers for Disease Control and Prevention (CDC), most cases of Lyme diseases are treated within 10 to 14 days of antibiotics.

Mayo Clinic notes that the standard treatment for Lyme disease is an antibiotic taken as a pill that lasts 10 to 14 days.

Cleveland Clinic also notes that while antibiotics are the primary treatment for Lyme disease, including doxycycline, amoxicillin, or cefuroxime axetil. The time taken to recover could be around 10 days.

Johns Hopkins Medicine notes that treatment could last up to 21 days.

What Is Lyme Disease?

It is a bacterial infection spread by infected ticks. The initial symptoms can include a 'bull's eye' rash, fever, headache, and fatigue. If it is left untreated, the infection could spread and cause more serious problems affecting joints, heart, and even the nervous system. It is most effectively treated, as many have noted and has been mentioned above, with antibiotics, especially when caught early.

End of Article

Measles Outbreak: Cases Surge In South Carolina; After US, Canada's Elimination Status Too Could Be Threatened

Updated Oct 29, 2025 | 07:43 AM IST

SummaryMeasles is resurging across North America. South Carolina’s outbreak has reached 25 cases, mostly among unvaccinated students, while New York’s Rockland County reported a second case in three months. Canada’s year-long transmission threatens its elimination status, with over 5,100 cases, and the U.S. risks losing its own status amid falling vaccination rates and misinformation.
Measles Outbreak: Cases Surge In South Carolina; After US, Canada's Elimination Status Too Could Be Threatened

Credits: Canva

Measles Outbreak: Measles is back again in America, with the Upstate South Carolina being hit by the outbreak again, and grown by 2 more cases. This has raised the state total to 25.

Health officials have confirmed that both the new infections were linked to close contacts of known cases. Those two in contact were under quarantine at home following exposures at two schools that had a high percentage of unvaccinated students. Of the state's 25 cases, 22 have occurred as part of the Upstate outbreak.

New York’s Rockland County has confirmed its second measles case in three months. The county, which saw a major measles outbreak in 2018–19 and has a sizable unvaccinated population, is once again on alert. Health officials said the new case is unrelated to the one reported in August, with the patient developing a rash soon after returning from an overseas trip last week.

Canada's Elimination Status Could Be Threatened By Measles Cases

October 28 marked one year of continuous measles transmission in Canada. This is a cycle of virus activity that is now threatening the country's elimination status.

As of now, the country has had more than 5,100 cases. This has been noted since the fall of 2024. This is more than double the number recorded in the past 25 years combined, which is why it is a cause of concern.

Canada had eliminated measles in past. In 1998, the disease was eliminated, however, with the new situation, the status of the country now seems to be in jeopardy. This is also because the elimination status requires an absence of the local virus transmission for at least 12 months.

According to CNN, the Pan American Health Organization (PAHO) is set to review and assess the measles elimination status of several North American countries during its annual meeting next month. In Canada, nearly 90% of the measles cases reported over the past year have occurred among unvaccinated individuals. Moreover, all but 157 of these cases have been linked to the ongoing outbreak that began in Ontario in October 2024.

In Israel too, as confirmed by The Jerusalem Post, eight child has died due to measles outbreak in the nation. The recent death is of a child, who was just 2-year-old. In Israel, all deaths in this outbreak have been noted in unvaccinated children under age 3 years.

Could US Too Lose Its Eliminated Status?

Measles has held “eliminated” status in the United States since 2000, a designation that means there had been no year-long, uncontrolled spread of the virus within the country for decades. But that milestone is now in jeopardy.

The infection is spreading again, and the Centers for Disease Control and Prevention (CDC) has reported 1,596 confirmed cases this year, the highest annual total in over thirty years. The actual number could be higher, says Dr. Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.

Why Are Cases Increasing In The US?

In Mohave County, Arizona, vaccination coverage among kindergartners dropped from 91% in 2019–20 to 78% in 2024–25, with a similar decline noted in southwest Utah.

Public health experts stress that at least 95% vaccination coverage is necessary to prevent the virus from spreading. Both Utah and Arizona allow parents to exempt children from school vaccine mandates on personal or religious grounds, leaving pockets of unprotected populations. Vaccine hesitancy has deepened since the Covid-19 pandemic, fueled by political polarization and a decline in public trust toward health authorities. Notably, most of the affected towns voted heavily for Donald Trump in the 2024 election, underscoring how politics and misinformation continue to shape vaccination decisions.

End of Article